Cambodia

The Long-Run Costs and Financing of HIV/AIDS in Cambodia

How can Cambodia best fight its HIV/AIDS epidemic? This report examines the long-term costs and epidemiological projections of HIV/AIDS in Cambodia.

Cambodia has made exceptional progress in addressing HIV/AIDS since it first appeared in the country in 1991. At the height of the epidemic in the early 1990s, approximately 15,500 people were becoming newly infected annually. Since then, Cambodia has greatly reduced the number of new infections – to about 2,100 in 2009. In addition, 93% percent of those eligible to receive antiretroviral therapy are currently in treatment.

Publication & Resource Type: 
Publications
Year Published: 
2010
Main Contact: 
Gabrielle Partridge
R4D Author(s): 
Richard Skolnik
R4D Author(s): 
Robert Hecht
Attached Publications & Resources: 

The Long-Run Costs and Financing of HIV/AIDS in Cambodia

3 January, 2011

"The Long-Run Costs and Financing of HIV/AIDS in Cambodia" was launched on December 21, 2010 in Phnom Penh, Cambodia. Robert Hecht, Results for Development Institute (R4D) Managing Director,  presented the findings at a meeting with the Cambodian Parliament.  

The Long-Run Costs and Financing of HIV/AIDS in Cambodia was launched on December 21, 2010,  in Phnom Penh, Cambodia.  Robert Hecht, Results for Development Institute (R4D) Managing Director, presented the report findings at a meeting with the Cambodia Parliament.

Connected Expert(s): 
Richard Skolnik
Connected Expert(s): 
Robert Hecht

Farzana Muhib discusses aids2031 findings on the BBC's Health Check

23 November, 2009

In preparation for World AIDS Day, the BBC invited Farzana Muhib, R4D's coordinator for the aids2031 Costs and Financing Project, to discuss future cost and financing scenarios for the global AIDS epidemic in their Health Check spotlight, "The Future for HIV/AIDS Funding."  Ms. Muhib highlighted the importance of "tough choice" spending policy decisions and more efficient management of resources now in order to curb future costs of the epidemic and achieve better health outcomes.

Connected Expert(s): 
Farzana Muhib
Funder: 
UNAIDS

aids2031: Costs and Financing Working Group

aids2031 is a international consortium of partners examining the future of the HIV/AIDS epidemic. The Costs and Financing Working Group is focused on modeling and analyzing the long-term costs and financing of the epidemic, and examining scenarios in which major policy shifts now can improve the future expenditure and financing situation.

Over the past 25 years, AIDS has imposed a huge cost, in economic and social terms, on many countries, communities, and households around the world. At the same time, the price tag to respond fully and effectively in the areas of prevention, care and treatment, mitigation, and research has grown to tens of billions of dollars, and is continuing to increase. There have been dramatic increases in funding, but available resources are now becoming increasingly tight as the global recession adversely impacts both donor and developing countries, and as other competing priorities (e.g.

Main Contact: 
Gabrielle Partridge
Duration: 
March, 2008 - June, 2010
Status: 
Active
Syndicate content